An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

April 9, 2024 updated by: Stephanie Manasse, Drexel University

Wellness Achieved Through Changing Habits (WATCH): An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

The goal of this clinical trial is to learn about cardiovascular disease risk among adolescent girls with overweight/obesity. The main questions this trial aims to answer are:

  1. Does an acceptance-based healthy lifestyle intervention demonstrate more weight loss than a health education intervention?
  2. Does an acceptance-based healthy lifestyle intervention show more improvements in participants' physiological, health-related, and psychological factors compared to a health education intervention?

Participants in this trial will:

  1. Engage in treatment for 6-months, comprising of a mixture of in-person and remote group sessions, occurring at Drexel University or over a video-conferencing platform.
  2. Complete various assessments. These include self-reported questionnaires, measures of weight, height, body composition, blood pressure, and blood lipids, and wearing of smart watches to measure sleep and physical activity.

Researchers will compare the acceptance-based and health education intervention groups to see if the acceptance-based treatment will indeed be effective in improving participants' health outcomes.

Study Overview

Detailed Description

Overweight/obesity (OW/OB) affects 14 million adolescents in the U.S. and disproportionately affects girls and racial/ethnic minorities while increasing their risk of cardiovascular disease (CVD) and type 2 diabetes. Adolescents demonstrate limited self-regulation skills, which are essential for adhering to diet and physical activity goals. Adolescents must contend with pervasive biological and environmental cues (e.g., cravings, labor-saving devices) that promote overeating and sedentary behavior. There is a critical need for interventions that teach self-regulation to enable adolescents to respond adaptively to these cues. Acceptance-based therapy (ABT) is an innovative approach that focuses on self-regulation skills, mindfulness, and increasing tolerance of uncomfortable internal experiences. There is strong evidence for ABT as an effective weight loss intervention for adults. The investigators conducted formative work using an adolescent-engaged approach to develop, implement, and feasibility test an ABT intervention for adolescent girls with OW/OB. The objective of this proposal is to test the efficacy of a novel ABT weight loss intervention tailored for adolescent girls with OW/OB.

This trial is the first to investigate ABT tailored for adolescent girls with OW/OB. The investigators will conduct a 6-month, randomized controlled trial comparing ABT with a health education comparison for 14- to 19-year-old adolescent girls with OW/OB, including ≥40% racial/ethnic minorities. To enhance scalability, interventions in both conditions will be delivered by bachelor's level paraprofessional weight loss coaches, treatment will occur in a hybrid of in-person and remote sessions, and the trial will take place in an outpatient community clinic. Assessments will be conducted at baseline, mid-treatment (month 3), post-treatment (month 6), 6-month follow-up (month 12), and 12-month follow-up (month 18), for a total study time of 18 months. The primary hypothesis is that adolescents randomized to ABT will exhibit significantly greater improvements in BMI z-score post-treatment compared to a health education comparison (HE). In the secondary aims, the investigators hypothesize that at post-treatment and 6- and 12-month follow-up, adolescents randomized to ABT will exhibit significantly greater improvements in their physiological, behavioral, and psychological risk factors compared to HE.

Study Type

Interventional

Enrollment (Estimated)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Drexel University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ages 14-19
  • Gender identification as girl
  • BMI percentile ≥ 85th percentile for sex-and-age

Exclusion Criteria:

  • Experience of weight loss of ≥5% of body weight in the past 6 months for any reason except post-partum weight loss
  • Having recently begun or changed the dosage of any medication known to affect appetite or body composition within the last 3 months
  • Plans to move out of the area within the next year
  • Active cancer or cancer requiring treatment in the past 2 years (except non-melanoma skin cancer)
  • Active or chronic infections (e.g., HIV or TB)
  • Active cardiovascular disease or event including hospitalization or therapeutic procedures for treatment of heart disease in the past 6 months
  • Active kidney disease
  • History of bariatric surgery
  • Lung disease: chronic obstructive airway disease requiring use of oxygen (e.g., emphysema or chronic bronchitis)
  • Diagnosed diabetes (type 1 or 2)
  • Any condition prohibiting physical activity
  • Diagnosis of an eating disorder
  • Have a mental handicap or are currently experiencing other severe psychopathology that would limit their ability to engage in the treatment program (e.g., severe depression, active psychotic disorder)
  • Recent or ongoing problem with drug abuse, alcohol abuse, or addiction
  • Currently pregnant or less than 3 months post-partum
  • Anticipation of a possible pregnancy in the next year
  • Unwillingness to report possible or confirmed pregnancies promptly during the course of the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acceptance-based Treatment (ABT)
ABT will consist of 18, 90-minute group sessions over 6 months.
Participants will be provided with psycho-education, skill-builders, and other coaching to promote weight loss and healthy lifestyle changes.
Sham Comparator: Health Education (HE) Comparison
HE will include nine, 75-minute group health education sessions handouts over 6 months.
Participants will be provided with psych-education and resources to promote weight loss and healthy lifestyle changes. They will not be provided with directives.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI z-score change
Time Frame: Month 6
Compare ABT vs. HE on BMI z-score change at post-treatment (month 6). The investigators hypothesize a significantly greater decrease in BMI z-scores in the ABT relative to HE.
Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological - Adiposity
Time Frame: Month 6, month 12, month 18
Compare change in percent body fat in ABT relative to HE
Month 6, month 12, month 18
Physiological - Blood pressure
Time Frame: Month 6, month 12, month 18
Compare change in diastolic and systolic blood pressure in ABT relative to HE
Month 6, month 12, month 18
Physiological - Blood lipids
Time Frame: Month 6, month 12, month 18
Compare change in total blood lipid levels in ABT relative to HE. HDL, LDL, and total cholesterol will each be examined.
Month 6, month 12, month 18
Health-related behaviors - dietary intake
Time Frame: Month 6, month 12, month 18
Compare change in dietary intake in ABT relative to HE. Dietary intake will be measured with a VioScreen Food Frequency Questionnaire.
Month 6, month 12, month 18
Health-related behaviors - physical activity
Time Frame: Month 6, month 12, month 18
Compare change in physical activity in ABT relative to HE. Physical activity will be measured with a smart watch.
Month 6, month 12, month 18
Psychological - Quality of life
Time Frame: Month 6, month 12, month 18
Compare change in quality of life, in ABT relative to HE. Quality of life will be measured with the Quality of Life Inventory.
Month 6, month 12, month 18
Psychological - Depression
Time Frame: Month 6, month 12, month 18
Compare change in depression in ABT relative to HE at all time points. Depression will be measured using Beck's Depression Inventory-II.
Month 6, month 12, month 18
Psychological - Disordered eating
Time Frame: Month 6, month 12, month 18
Compare change in disordered eating in ABT relative to HE at all time points. Disordered eating will be measured using the Eating Disorder Examination Questionnaire.
Month 6, month 12, month 18
Psychological - Psychological flexibility
Time Frame: Month 6, month 12, month 18
Compare change in psychological flexibility in ABT relative to HE at all time points. Psychological flexibility will be measured using the Acceptance and Action Questionnaire II.
Month 6, month 12, month 18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Manasse, PhD, Drexel University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2024

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

November 10, 2023

First Submitted That Met QC Criteria

November 17, 2023

First Posted (Actual)

November 28, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be shared with the study Data Safety Monitoring Board (DSMB). Following study close-out, de-identified data and related data dictionaries will be available upon request.

IPD Sharing Time Frame

Data will be available upon request following the conclusion of the study.

IPD Sharing Access Criteria

For access, interested parties must contact the principal investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Acceptance-based Treatment (ABT)

Subscribe